COMPOSITIONS AND METHODS FOR TREATING DIFFUSE LARGE B CELL LYMPHOMA
Methods and compositions for treating diffuse large B cell lymphoma (DLBCL) using a combination of blinatumomab and/or a blinatumomab variant and pembrolizumab, a pembrolizumab variant and/or an antigen-binding fragment thereof, are provided. 提供了使用博纳吐单抗和/或博纳吐单抗变体与派姆单抗、派姆单抗变体和/或其抗原结合片段的组合用于治疗弥漫性大B细胞淋...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
29.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods and compositions for treating diffuse large B cell lymphoma (DLBCL) using a combination of blinatumomab and/or a blinatumomab variant and pembrolizumab, a pembrolizumab variant and/or an antigen-binding fragment thereof, are provided.
提供了使用博纳吐单抗和/或博纳吐单抗变体与派姆单抗、派姆单抗变体和/或其抗原结合片段的组合用于治疗弥漫性大B细胞淋巴瘤(DLBCL)的方法和组合物。 |
---|---|
Bibliography: | Application Number: CN201880066675 |